<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background/Aims: We measured the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels of thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD) and <z:chebi fb="0" ids="30839">orotate</z:chebi> phosphoribosyl transferase (OPRT) in <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and retrospectively analyzed their association with other clinicopathological factors and the prognosis of these patients </plain></SENT>
<SENT sid="1" pm="."><plain>Methodology: The study involved 55 patients of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> who underwent surgery at our department between February 1988 and April 2003 </plain></SENT>
<SENT sid="2" pm="."><plain>Results: Analysis of the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels of each of the aforementioned enzymes in the <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> revealed no significant differences in the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels of the enzymes depending on the timing of development of the <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e>, histological type of the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, or the patient gender </plain></SENT>
<SENT sid="3" pm="."><plain>In the analysis of the survival period, no association was observed between the survival prognosis and the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression level of DPD or OPRT in the <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e>; on the other hand, the prognosis was better in the group showing low TS <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression (median survival period: 3.77 years) than in the group showing high TS <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression (median survival period: 2.39 years) (p=0.0134) </plain></SENT>
<SENT sid="4" pm="."><plain>Conclusions: These results suggest that the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression level of TS in the <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients is a useful prognostic indicator </plain></SENT>
</text></document>